key: cord-0296926-blkblkg8
authors: Gazzinelli-Guimaraes, P. H.; Sanku, G.; Sette, A.; Weiskopf, D.; Schaughency, P.; Lack, J.; Nutman, T.
title: Antigenic determinants of SARS-CoV-2-specific CD4+ T cell lines reveals M protein-driven dysregulation of interferon signaling
date: 2022-01-21
journal: nan
DOI: 10.1101/2022.01.20.22269491
sha: 70f84aba7100c44b8913355cd20bc240cf91f704
doc_id: 296926
cord_uid: blkblkg8

We generated CD4+ T cell lines (TCLs) reactive to either SARSCoV-2 spike (S) or membrane (M) proteins from unexposed naive T cells from six healthy donor volunteers to understand in fine detail whether the S and M structural proteins have intrinsic differences in driving antigen-specific CD4+ T cell responses. Having shown that each of the TCLs were antigen-specific and antigen-reactive, single cell mRNA analyses demonstrated that SARS-CoV-2 S and M proteins drive strikingly distinct molecular signatures. Whereas the S-specific responses are virtually indistinguishable from those responses induced by other viral antigens (e.g. CMV), the M protein-specific CD4+ TCLs have a transcriptomic signature that indicate a marked suppression of interferon signaling, characterized by a downregulation of the genes encoding ISG15, IFITM1, IFI6, MX1, STAT1, OAS1, IFI35, IFIT3 and IRF7 (a molecular signature which is not dissimilar to that found in severe COVID-19). Our study suggests a potential link between the antigen specificity of the SARS-CoV-2-reactive CD4+ T cells and the development of specific sets of adaptive immune responses. Moreover, the balance between T cells of significantly different specificities may be the key to understand how CD4+ T cell dysregulation can determine the clinical outcomes of COVID-19.

This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 21, 2022. ; https://doi.org/10.1101 https://doi.org/10. /2022 next step was to use the molecular signature of M protein-reactive T cells to understand how they 154 relate to other diseases and functions through the IPA™ ontology. The transcriptome of SARS-155

Cov-2 M protein-reactive CD4 + TCLs revealed pathways associated with a diverse list of This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 21, 2022. The relationship between antigen-specific CD4 + T cell responses and COVID-19 severity 186 remains unclear. First it has been demonstrated that mild COVID-19 patients, who typically 187 recover without special treatment, showed broad SARS-CoV-2-specific CD4 + T cell responses to 188 S and N proteins, responses that were highly correlated with specific antibody titers [18] . This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 21, 2022. ;

Notably, through signal cell RNAseq analysis of T-cell dysregulation in severe COVID-220 19 it has been demonstrated that CD4 + T cells from severe COVID-19 patients expressed higher 221 levels of a set of inflammatory genes that include FOS, FOSB, JUN and others, gene expression 222

[33] not dissimilar to those found in our M-specific TCLs derived from SARS-CoV-2 unexposed 223 individuals. In parallel, this same study showed that CD4 + T cells from patients with severe 224 COVID-19 showed decreased expression of interferon-induced genes including IFIT1, IFIT2, 225 IFIT3, and IFITM1 and those downstream from interferon signaling [33], again striking similar 226 to the molecular signature seen in the M protein-reactive CD4 + TCLs in this present study. 227 

In conclusion, although it has been poorly understood how CD4 + T cell dysregulation can 234 contribute to the immunopathogenesis of severe COVID-19, our study suggests a potential link 235 between the antigen specificity of the reactive CD4 + T cells to SARS-CoV-2 with the 236 development of a functional and efficient adaptive immune response. The discordant response to 237 for use under a CC0 license. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 21, 2022. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 21, 2022. ; https://doi.org/10.1101/2022.01.20.22269491 doi: medRxiv preprint This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 21, 2022. ; https://doi.org/10.1101 https://doi.org/10. /2022 This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 21, 2022. View highlighting how the SARS-Cov-2 specific-CD4 + TCLs relate to other diseases and 500 functions through the ingenuity ontology (B). Severe COVID-19 associated genes that overlap 501 with the marked differentially expressed genes in the SARS-Cov-2 M protein-reactive CD4 + 502 TCLs (C). 503

for use under a CC0 license. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 21, 2022. ; https://doi.org/10. 1101 /2022 

SARS-CoV-2-derived peptides define heterologous and COVID-19-384 induced T cell recognition

Broad and strong memory CD4(+) and CD8(+) T cells induced by SARS-386

CoV-2 in UK convalescent individuals following COVID-19

T-Cell Hyperactivation and Paralysis in Severe COVID-19 Infection